Evidence map›Paper›PMID 25477492›Full record

ReviewCirculation research2014

Macrophage functions in atherosclerosis.

Iris Zeller, Sanjay Srivastava

Abstract readReview
In one paragraph

Review in Circulation research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Human Macrophage Long Intergenic Noncoding RNA,Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Iris ZellerFrom the Institute of Molecular Cardiology and Diabetes and Obesity Center, University of Louisville, KY 40202.
Sanjay SrivastavaFrom the Institute of Molecular Cardiology and Diabetes and Obesity Center, University of Louisville, KY 40202. sanjay@louisville.edu.

Funding

Research Training and Education Core (Core D) P50HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2013 to 2017
$20.1M
ConProject-006U54HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2018 to 2022
$18.8M
Project 5 - Metabolomic Analysis of AtherothrombosisP20GM103492 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DEFILIPPIS, ANDREW · 2012 to 2017
$13.8M
Atherogenic Mechanisms of ArsenicR01ES017260 · NIEHS · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2009 to 2013
$1.6M
Atherogenic mechanism of lipid peroxidation-derived aldehydesR01HL095593 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SRIVASTAVA, SANJAY · 2010 to 2013
$1.5M
NHLBI NIH HHS HL95593NHLBI NIH HHS P50 HL120163NHLBI NIH HHS R01 HL095593NHLBI NIH HHS U54 HL120163NIEHS NIH HHS ES17260NIEHS NIH HHS R01 ES017260NIGMS NIH HHS GM 103492NIGMS NIH HHS P20 GM103492
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsArteriesAtherosclerosisCardiovascular AgentsHumansMacrophagesSignal TransductionCardiovascular Agents

Identifiers

PMID25477492
PMCPMC4414311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.